The story of Sildenafil presents a complex picture for those considering investment. While the initial introduction generated significant gains, the expiration of its patent opened the avenue to generic competitors, dramatically eroding revenue. This creates a unique challenge for firms banking on related Gambling blockbuster medications, suggestin

The history of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in sales , its intellectual property lapse created a flood of knock-off medications, significantly eroding its market share . While certain pharmaceutical companies may seek to capitalize on male sexu